converting between glp 1 agonists Strategies to Enhance the Therapeutic Efficacy of GLP‐1 Receptor through Structural Modification and Carrier Delivery - Zhang - 2025 - ChemBioChem GLP-1 receptor agonist use may

GLP-1R, glucagon-like peptide-1 receptor

Orexigenic neurons, which stimulate appetite, produce neuropeptide Y (NPY) and agouti-related peptide (AgRP)

For example, the study found GLP-1 users had a 7% greater risk of developing gastroparesis compared with people who were using other types of medications to lower their blood sugar

We now know after more than 15 years of GLP-1 therapy that we can see cardioprotection, reduction in blood pressure, and we know we can see a reduction in body weight, Davies said

4 For example, ADA and KDIGO joint group has recommended that for patients with T2DM and CKD who do not achieve their glycemic target with metformin and/or an SGLT2i or cannot use them, a GLP-1RAs with proven cardiovascular benefit is recommended